Mylan Inc (MYL)

MYL (NASDAQ:Drugs)
$45.69
pos +0.20
+0.44%
Today's Range: 45.32 - 45.73 | MYL Avg Daily Volume: 4,843,200
Last Update: 10/01/14 - 10:21 AM EDT
Volume: 551,282
YTD Performance: 4.82%
Open: $45.64
Previous Close: $45.49
52 Week Range: $36.97 - $57.52
Oustanding Shares: 374,047,341
Market Cap: 17,127,627,744
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 10 12 9
Moderate Buy 0 0 0 0
Hold 2 2 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.36 1.33 1.15 1.36
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 31.15
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
31.15 31.30 28.41
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-11.77% 19.18% 167.75%
GROWTH 12 Mo 3 Yr CAGR
Revenue 1.70 0.27 0.08
Net Income -2.60 0.81 0.22
EPS 3.70 1.36 0.33
Earnings for MYL:
EBITDA 1.64B
Revenue 6.91B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.93 $0.97 $3.27 $4.01
Number of Analysts 7 6 8 8
High Estimate $0.96 $1.01 $3.35 $4.21
Low Estimate $0.90 $0.94 $3.22 $3.69
Prior Year $0.82 $0.78 $2.89 $3.27
Growth Rate (Year over Year) 13.76% 24.79% 13.19% 22.43%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Four stocks that have been trading in triangle or wedge patterns.

This Morning's Market Setup Real Money Pro($)

Where it began.
Update
Sep 18, 2014 | 7:01 AM EDT
MYL - Mylan Inc Investor Day - NY
And a paucity of perky charts.

This Morning's Market Setup Real Money Pro($)

Where it began.
A wave of M&A in the health sector makes sense.
I will explore Gannett because I love firms with many owned assets.
Update
Apr 11, 2014 | 7:04 AM EDT
MYL - Mylan Inc. Annual Shareholders Meeting - 10:30AM
Bullish
Apr 07, 2014 | 7:57 AM EDT
MYL was upgraded to Buy, Citigroup said. $61 price target. Meda purchase appears to make strategic and financial sense. 
Bearish
Apr 04, 2014 | 8:10 AM EDT
Shares of MYL now seen reaching $58, according to Leerink Swann. Estimates also reduced, given prescription trends and new product dela...

Columnist Conversations

VIX did not care one wit for the decent jobs report. Stocks are trading on Ebola, HK, ISIS, Russia and other ...
My baseline view of the December Es contract, and the market as a whole remains unchanged. I continue to belie...
I mentioned the eveningstar pattern on the daily chart of the DJIA
Stocks to watch this morning include…Nice breakfast…General Mills is laying off 800 salaried wor...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.